173 related articles for article (PubMed ID: 29022915)
21. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
[TBL] [Abstract][Full Text] [Related]
22. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
23. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
25. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
Wang L; Yu P
Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
[TBL] [Abstract][Full Text] [Related]
26. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
27. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
28. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
Luna MC; Ferrario A; Wong S; Fisher AM; Gomer CJ
Cancer Res; 2000 Mar; 60(6):1637-44. PubMed ID: 10749134
[TBL] [Abstract][Full Text] [Related]
30. The miR-34a/WNT7B modulates the sensitivity of cholangiocarcinoma cells to p53-mediated photodynamic therapy toxicity.
Han Y; Yang Y; Huang S; Yao L; Wu L
Biochem Biophys Res Commun; 2022 Feb; 591():54-61. PubMed ID: 34999254
[TBL] [Abstract][Full Text] [Related]
31. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway.
Yang P; Yang Y; An W; Xu J; Zhang G; Jie J; Zhang Q
J Gastroenterol Hepatol; 2017 Apr; 32(4):837-845. PubMed ID: 27696511
[TBL] [Abstract][Full Text] [Related]
32. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
[TBL] [Abstract][Full Text] [Related]
34. Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.
Kim YJ; Lee JH; Jin S; Kim JH; Kim SH
Cancer Lett; 2019 Jan; 440-441():168-179. PubMed ID: 30393117
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
36. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
[TBL] [Abstract][Full Text] [Related]
37. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
38. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
39. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
40. MiR-340/iASPP axis affects UVB-mediated retinal pigment epithelium (RPE) cell damage.
Yan J; Qin Y; Yu J; Peng Q; Chen X
J Photochem Photobiol B; 2018 Sep; 186():9-16. PubMed ID: 29982095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]